InvestorsHub Logo
Post# of 200740
Next 10
Followers 39
Posts 3096
Boards Moderated 0
Alias Born 03/17/2019

Re: None

Saturday, 04/18/2020 12:39:45 PM

Saturday, April 18, 2020 12:39:45 PM

Post# of 200740
IMHO, solution sales is the driver here. The Instrument that develops the solution is more than likely (JITD) Just In Time Delivery. It make more sense to do this than to stock pile and pay Manufacturing cost upfront before it is sold.

The Plant can make runs of solution as needed as well (JITD), it has a short shelf life and has to gain access to sites right now. That is why you see the company hire new workers, that is because solution sales at manufacturer is in a parabolic state, with an insuing rapid downturn once we cross the peak of COVID.

At such time, the instrument that develops the solution will then began to arrive at said locations that purchased solutions during the peak of COVID.

Sales of units are picking up rapidly as well, but also keep in mind logistics and Manufacturing capabilities during COVID. High Priority are Drugs, VENTS, Food, and other instruments needed to combat COVID.

Ground shipment from Manufacturer of instruments from PCTL direct to purchaser is critical.

(BLUF) Sales of solution will be very significant, the Instruments FUTURES are also very significant. I suspect this coming week we will see sales reports of SOLUTIONS first, with follow along trailing data sales of instruments, throughout the US and Global.

Is it a fare price target of $34 PPS? IMHO Yes, the question is time to horizon of said price and performance of shorts. I plan to hold through COVID 100% of shares I currently have.

Could very well be a target for the Big Guys to snatch-up as well, and then you will certainly see that $34 PPS Target hit overnight.

The risk of missing a huge moves is not worth the flip.